|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-6-15
|
|
pubmed:abstractText |
Percutaneous injection therapy using acetic acid or pure ethanol is effective for hepatocellular carcinoma (HCC). However, its efficacy in HCC patients with coexisting chronic renal insufficiency (CRI), defined as a serum creatinine level of 1.5 mg/dl or above, is not known. This study compared the survival in HCC patients with and without CRI undergoing percutaneous injection therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-31
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:15195898-Acetic Acid,
pubmed-meshheading:15195898-Aged,
pubmed-meshheading:15195898-Antineoplastic Agents,
pubmed-meshheading:15195898-Ascites,
pubmed-meshheading:15195898-Carcinoma, Hepatocellular,
pubmed-meshheading:15195898-Creatinine,
pubmed-meshheading:15195898-Ethanol,
pubmed-meshheading:15195898-Female,
pubmed-meshheading:15195898-Humans,
pubmed-meshheading:15195898-Injections, Intralesional,
pubmed-meshheading:15195898-Kidney Failure, Chronic,
pubmed-meshheading:15195898-Liver Neoplasms,
pubmed-meshheading:15195898-Male,
pubmed-meshheading:15195898-Survival Analysis,
pubmed-meshheading:15195898-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.
|
|
pubmed:affiliation |
Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China. tihuo@vghtpe.gov.tw
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
